These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 7797599)

  • 21. Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity.
    Duncan RE; Lau D; El-Sohemy A; Archer MC
    Biochem Pharmacol; 2004 Nov; 68(9):1739-47. PubMed ID: 15450939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of low density lipoprotein receptor by gemfibrozil, a hypolipidemic agent, in human hepatoma cells through stabilization of mRNA transcripts.
    Goto D; Okimoto T; Ono M; Shimotsu H; Abe K; Tsujita Y; Kuwano M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2707-12. PubMed ID: 9409246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation by plasma lipoproteins of progesterone biosynthesis and 3-hydroxy-3-methyl glutaryl coenzyme a reductase activity in cultured human choriocarcinoma cells.
    Simpson ER; Porter JC; Milewich L; Bilheimer DW; MacDonald PC
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1099-105. PubMed ID: 263339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pravastatin sodium, a new HMG-CoA reductase inhibitor.
    Raasch RH
    DICP; 1991 Apr; 25(4):388-94. PubMed ID: 1926908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA contents in human hepatoma cell line Hep G2 by distinct classes of mevalonate-derived metabolites.
    Cohen LH; Griffioen M
    Biochem J; 1988 Oct; 255(1):61-7. PubMed ID: 2848511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased transforming growth factor-beta(1) circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin.
    Porreca E; Di Febbo C; Baccante G; Di Nisio M; Cuccurullo F
    J Am Coll Cardiol; 2002 Jun; 39(11):1752-7. PubMed ID: 12039487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
    Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
    FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SC-435, an ileal apical sodium-codependent bile acid transporter inhibitor alters mRNA levels and enzyme activities of selected genes involved in hepatic cholesterol and lipoprotein metabolism in guinea pigs.
    West KL; McGrane M; Odom D; Keller B; Fernandez ML
    J Nutr Biochem; 2005 Dec; 16(12):722-8. PubMed ID: 16169202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of pravastatin on hepatic 3-hydroxy-3-methylglutaryl CoA reductase obtained from poloxamer 407-induced hyperlipidemic rats.
    Johnston TP; Palmer WK
    Pharmacotherapy; 1997; 17(2):342-7. PubMed ID: 9085326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quantitative analysis of mRNA expression of the LDL receptor and HMG-CoA reductase in bovine tissue with competitive RT-PCR].
    Niendorf A; Gebhardt A
    Pathologe; 1994 Aug; 15(4):201-6. PubMed ID: 7971794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Mediterranean-style, low-glycemic-load diet reduces the expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in mononuclear cells and plasma insulin in women with metabolic syndrome.
    Jones JL; Park Y; Lee J; Lerman RH; Fernandez ML
    Nutr Res; 2011 Sep; 31(9):659-64. PubMed ID: 22024489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collagen secretion and growth of mesangial cells require geranylgeranylpyrophosphate.
    Nishimura M; Tanaka T; Yasuda T; Kurakata S; Kitagawa M; Yamada K; Saito Y; Hirai A
    Kidney Int; 1999 Feb; 55(2):520-8. PubMed ID: 9987076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of sterol synthesis by the monoterpene perillyl alcohol is unaffected by competitive 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.
    Cerda SR; Wilkinson J; Branch SK; Broitman SA
    Lipids; 1999 Jun; 34(6):605-15. PubMed ID: 10405975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats.
    Fujioka T; Nara F; Tsujita Y; Fukushige J; Fukami M; Kuroda M
    Biochim Biophys Acta; 1995 Jan; 1254(1):7-12. PubMed ID: 7811749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins.
    Perchellet JP; Perchellet EM; Crow KR; Buszek KR; Brown N; Ellappan S; Gao G; Luo D; Minatoya M; Lushington GH
    Int J Mol Med; 2009 Nov; 24(5):633-43. PubMed ID: 19787197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.
    Straka MS; Panini SR
    Arch Biochem Biophys; 1995 Feb; 317(1):235-43. PubMed ID: 7872789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo LDL receptor and HMG-CoA reductase regulation in human lymphocytes and its alterations during aging.
    Stulnig TM; Klocker H; Harwood HJ; Jürgens G; Schönitzer D; Jarosch E; Huber LA; Amberger A; Wick G
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):872-8. PubMed ID: 7541292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of short-term treatment with pravastatin on the hepatic synthesis of cholesterol and bile acids in gallstone patients.
    Hillebrant CG; Axelson M; Björkhem I; Wang FH; Nyberg B; Einarsson C
    Eur J Clin Invest; 1998 Apr; 28(4):324-8. PubMed ID: 9615912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of single administration of pravastatin sodium on hepatic cholesterol metabolism in rats.
    Fujioka T; Tsujita Y
    Eur J Pharmacol; 1997 Apr; 323(2-3):223-8. PubMed ID: 9128842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.